annual cost of goods sold:
$1.53B+$268.30M(+21.26%)Summary
- As of today (May 18, 2025), VRTX annual cost of goods sold is $1.53 billion, with the most recent change of +$268.30 million (+21.26%) on December 31, 2024.
- During the last 3 years, VRTX annual cost of goods sold has risen by +$626.30 million (+69.27%).
- VRTX annual cost of goods sold is now at all-time high.
Performance
VRTX Cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cost of goods sold:
$363.00M-$60.40M(-14.27%)Summary
- As of today (May 18, 2025), VRTX quarterly cost of goods sold is $363.00 million, with the most recent change of -$60.40 million (-14.27%) on March 31, 2025.
- Over the past year, VRTX quarterly cost of goods sold has increased by +$20.40 million (+5.95%).
- VRTX quarterly cost of goods sold is now -14.27% below its all-time high of $423.40 million, reached on December 31, 2024.
Performance
VRTX quarterly cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM cost of goods sold:
$1.55B+$20.40M(+1.33%)Summary
- As of today (May 18, 2025), VRTX TTM cost of goods sold is $1.55 billion, with the most recent change of +$20.40 million (+1.33%) on March 31, 2025.
- Over the past year, VRTX TTM cost of goods sold has increased by +$213.00 million (+15.92%).
- VRTX TTM cost of goods sold is now at all-time high.
Performance
VRTX TTM cost of goods sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cost of goods sold Formula
COGS = Beginning Inventory + Purchases − Ending Inventory
VRTX Cost of goods sold Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +21.3% | +6.0% | +15.9% |
3 y3 years | +69.3% | +47.7% | +61.9% |
5 y5 years | +179.4% | +123.4% | +152.1% |
VRTX Cost of goods sold Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +69.3% | -14.3% | +47.7% | at high | +61.9% |
5 y | 5-year | at high | +179.4% | -14.3% | +123.4% | at high | +152.1% |
alltime | all time | at high | >+9999.0% | -14.3% | +1504.7% | at high | >+9999.0% |
VRTX Cost of goods sold History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $363.00M(-14.3%) | $1.55B(+1.3%) |
Dec 2024 | $1.53B(+21.3%) | $423.40M(+7.8%) | $1.53B(+3.8%) |
Sep 2024 | - | $392.60M(+5.6%) | $1.48B(+5.3%) |
Jun 2024 | - | $371.90M(+8.6%) | $1.40B(+4.7%) |
Mar 2024 | - | $342.60M(-6.9%) | $1.34B(+6.0%) |
Dec 2023 | $1.26B(+16.8%) | $368.00M(+15.5%) | $1.26B(+7.2%) |
Sep 2023 | - | $318.70M(+3.3%) | $1.18B(+2.6%) |
Jun 2023 | - | $308.60M(+15.6%) | $1.15B(+4.2%) |
Mar 2023 | - | $266.90M(-5.8%) | $1.10B(+2.0%) |
Dec 2022 | $1.08B(+19.5%) | $283.30M(-2.1%) | $1.08B(+3.4%) |
Sep 2022 | - | $289.40M(+10.5%) | $1.04B(+5.3%) |
Jun 2022 | - | $261.80M(+6.5%) | $991.50M(+3.5%) |
Mar 2022 | - | $245.80M(-0.6%) | $957.70M(+5.9%) |
Dec 2021 | $904.20M(+22.8%) | $247.40M(+4.6%) | $904.20M(+5.2%) |
Sep 2021 | - | $236.50M(+3.7%) | $859.90M(+6.2%) |
Jun 2021 | - | $228.00M(+18.6%) | $809.58M(+5.7%) |
Mar 2021 | - | $192.30M(-5.3%) | $766.10M(+4.0%) |
Dec 2020 | $736.30M(+34.4%) | $203.10M(+9.1%) | $736.30M(+2.5%) |
Sep 2020 | - | $186.18M(+0.9%) | $718.25M(+8.2%) |
Jun 2020 | - | $184.52M(+13.6%) | $663.99M(+7.9%) |
Mar 2020 | - | $162.50M(-12.2%) | $615.21M(+12.3%) |
Dec 2019 | $547.80M(+33.8%) | $185.05M(+40.3%) | $547.80M(+12.9%) |
Sep 2019 | - | $131.91M(-2.8%) | $485.04M(+4.4%) |
Jun 2019 | - | $135.74M(+42.7%) | $464.38M(+7.2%) |
Mar 2019 | - | $95.09M(-22.2%) | $433.02M(+5.7%) |
Dec 2018 | $409.54M(+48.9%) | $122.29M(+9.9%) | $409.54M(+10.3%) |
Sep 2018 | - | $111.25M(+6.6%) | $371.30M(+11.5%) |
Jun 2018 | - | $104.38M(+45.8%) | $332.92M(+11.1%) |
Mar 2018 | - | $71.61M(-14.8%) | $299.74M(+9.0%) |
Dec 2017 | $275.12M(+30.7%) | $84.05M(+15.3%) | $275.12M(+9.4%) |
Sep 2017 | - | $72.87M(+2.3%) | $251.55M(+8.1%) |
Jun 2017 | - | $71.20M(+51.5%) | $232.75M(+12.5%) |
Mar 2017 | - | $46.99M(-22.3%) | $206.80M(-1.7%) |
Dec 2016 | $210.46M(+69.0%) | $60.48M(+11.8%) | $210.46M(-1.4%) |
Sep 2016 | - | $54.08M(+19.5%) | $213.36M(+11.6%) |
Jun 2016 | - | $45.25M(-10.7%) | $191.25M(+17.4%) |
Mar 2016 | - | $50.65M(-20.1%) | $162.85M(+30.8%) |
Dec 2015 | $124.51M(+104.2%) | $63.38M(+98.3%) | $124.51M(+65.7%) |
Sep 2015 | - | $31.96M(+89.6%) | $75.15M(+31.0%) |
Jun 2015 | - | $16.86M(+37.0%) | $57.38M(-0.8%) |
Mar 2015 | - | $12.31M(-12.3%) | $57.82M(-5.2%) |
Dec 2014 | $60.99M(-53.2%) | $14.03M(-1.1%) | $60.99M(-11.9%) |
Sep 2014 | - | $14.18M(-18.0%) | $69.22M(-16.0%) |
Jun 2014 | - | $17.30M(+11.8%) | $82.38M(-20.0%) |
Mar 2014 | - | $15.48M(-30.5%) | $103.01M(-20.9%) |
Dec 2013 | $130.28M(-53.5%) | $22.26M(-18.6%) | $130.28M(-33.4%) |
Sep 2013 | - | $27.34M(-27.9%) | $195.73M(-5.4%) |
Jun 2013 | - | $37.93M(-11.3%) | $206.93M(-27.0%) |
Mar 2013 | - | $42.74M(-51.3%) | $283.42M(+1.3%) |
Dec 2012 | $279.88M(+247.7%) | $87.72M(+127.6%) | $279.88M(+25.9%) |
Sep 2012 | - | $38.54M(-66.3%) | $222.30M(+0.1%) |
Jun 2012 | - | $114.42M(+191.8%) | $222.17M(+89.8%) |
Mar 2012 | - | $39.21M(+30.2%) | $117.05M(+45.4%) |
Dec 2011 | $80.50M(+532.4%) | $30.13M(-21.6%) | $80.50M(+50.7%) |
Sep 2011 | - | $38.41M(+312.7%) | $53.43M(+192.8%) |
Jun 2011 | - | $9.31M(+249.1%) | $18.25M(+51.7%) |
Mar 2011 | - | $2.67M(-12.6%) | $12.03M(-5.5%) |
Dec 2010 | $12.73M(-10.4%) | $3.05M(-5.5%) | $12.73M(-4.5%) |
Sep 2010 | - | $3.23M(+4.6%) | $13.33M(-3.5%) |
Jun 2010 | - | $3.09M(-8.3%) | $13.81M(-1.3%) |
Mar 2010 | - | $3.37M(-7.7%) | $13.99M(-1.5%) |
Dec 2009 | $14.20M(-9.5%) | $3.65M(-1.8%) | $14.20M(-3.8%) |
Sep 2009 | - | $3.71M(+13.6%) | $14.77M(-3.2%) |
Jun 2009 | - | $3.27M(-8.6%) | $15.25M(-2.8%) |
Mar 2009 | - | $3.58M(-15.2%) | $15.69M(0.0%) |
Dec 2008 | $15.69M | $4.21M(+0.5%) | $15.69M(+3.6%) |
Sep 2008 | - | $4.19M(+13.3%) | $15.14M(+4.4%) |
Jun 2008 | - | $3.70M(+3.5%) | $14.51M(+2.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | - | $3.58M(-2.6%) | $14.21M(+2.2%) |
Dec 2007 | $13.90M(+14.2%) | $3.67M(+3.1%) | $13.90M(+3.7%) |
Sep 2007 | - | $3.56M(+4.7%) | $13.41M(+3.5%) |
Jun 2007 | - | $3.40M(+4.0%) | $12.96M(+4.1%) |
Mar 2007 | - | $3.27M(+2.9%) | $12.44M(+2.3%) |
Dec 2006 | $12.17M(+20.5%) | $3.18M(+2.1%) | $12.17M(+3.3%) |
Sep 2006 | - | $3.11M(+7.9%) | $11.78M(+2.8%) |
Jun 2006 | - | $2.88M(-3.7%) | $11.46M(+3.6%) |
Mar 2006 | - | $3.00M(+7.6%) | $11.06M(+9.6%) |
Dec 2005 | $10.10M(+78.8%) | $2.78M(-0.5%) | $10.10M(+8.3%) |
Sep 2005 | - | $2.80M(+12.3%) | $9.32M(+16.6%) |
Jun 2005 | - | $2.49M(+22.6%) | $7.99M(+17.0%) |
Mar 2005 | - | $2.03M(+1.0%) | $6.83M(+21.0%) |
Dec 2004 | $5.65M(+80.7%) | $2.01M(+37.0%) | $5.65M(+21.5%) |
Sep 2004 | - | $1.47M(+10.4%) | $4.65M(+16.8%) |
Jun 2004 | - | $1.33M(+57.0%) | $3.98M(-5.0%) |
Mar 2004 | - | $846.00K(-16.2%) | $4.19M(-38.9%) |
Dec 2003 | $3.13M(-6.2%) | $1.01M(+26.6%) | $6.86M(-154.9%) |
Sep 2003 | - | $797.00K(-48.2%) | -$12.50M(+86.1%) |
Jun 2003 | - | $1.54M(-56.2%) | -$6.72M(+274.8%) |
Mar 2003 | - | $3.52M(-119.2%) | -$1.79M(-153.7%) |
Dec 2002 | $3.33M(-7.2%) | -$18.35M(-378.9%) | $3.33M(-180.1%) |
Sep 2002 | - | $6.58M(+1.8%) | -$4.16M(+2137.6%) |
Jun 2002 | - | $6.46M(-25.2%) | -$186.00K(-96.8%) |
Mar 2002 | - | $8.64M(-133.4%) | -$5.73M(-57.7%) |
Dec 2001 | $3.59M(-92.3%) | -$25.84M(-344.9%) | -$13.53M(-121.6%) |
Sep 2001 | - | $10.55M(+1045.8%) | $62.52M(+23.1%) |
Jun 2001 | - | $921.00K(+10.0%) | $50.80M(+4.0%) |
Mar 2001 | - | $837.00K(-98.3%) | $48.87M(+4.1%) |
Dec 2000 | $46.93M(-1480.3%) | $50.21M(-4402.5%) | $46.93M(-1196.5%) |
Sep 2000 | - | -$1.17M(+15.5%) | -$4.28M(+4.1%) |
Jun 2000 | - | -$1.01M(-8.4%) | -$4.11M(+23.9%) |
Mar 2000 | - | -$1.10M(+10.3%) | -$3.32M(-2.8%) |
Dec 1999 | -$3.40M(-24.4%) | -$1.00M(0.0%) | -$3.42M(-10.5%) |
Sep 1999 | - | -$1.00M(+360.8%) | -$3.82M(-2.6%) |
Jun 1999 | - | -$217.00K(-81.9%) | -$3.92M(-18.4%) |
Mar 1999 | - | -$1.20M(-14.3%) | -$4.80M(+6.7%) |
Dec 1998 | -$4.50M(+25.0%) | -$1.40M(+27.3%) | -$4.50M(+9.8%) |
Sep 1998 | - | -$1.10M(0.0%) | -$4.10M(+2.5%) |
Jun 1998 | - | -$1.10M(+22.2%) | -$4.00M(+8.1%) |
Mar 1998 | - | -$900.00K(-10.0%) | -$3.70M(+2.8%) |
Dec 1997 | -$3.60M(+12.5%) | -$1.00M(0.0%) | -$3.60M(+9.1%) |
Sep 1997 | - | -$1.00M(+25.0%) | -$3.30M(+6.5%) |
Jun 1997 | - | -$800.00K(0.0%) | -$3.10M(-3.1%) |
Mar 1997 | - | -$800.00K(+14.3%) | -$3.20M(0.0%) |
Dec 1996 | -$3.20M(-13.5%) | -$700.00K(-12.5%) | -$3.20M(-8.6%) |
Sep 1996 | - | -$800.00K(-11.1%) | -$3.50M(-5.4%) |
Jun 1996 | - | -$900.00K(+12.5%) | -$3.70M(+5.7%) |
Mar 1996 | - | -$800.00K(-20.0%) | -$3.50M(-5.4%) |
Dec 1995 | -$3.70M(+5.7%) | -$1.00M(0.0%) | -$3.70M(0.0%) |
Sep 1995 | - | -$1.00M(+42.9%) | -$3.70M(+5.7%) |
Jun 1995 | - | -$700.00K(-30.0%) | -$3.50M(-5.4%) |
Mar 1995 | - | -$1.00M(0.0%) | -$3.70M(+2.8%) |
Dec 1994 | -$3.50M(-10.3%) | -$1.00M(+25.0%) | -$3.60M(-2.7%) |
Sep 1994 | - | -$800.00K(-11.1%) | -$3.70M(-2.6%) |
Jun 1994 | - | -$900.00K(0.0%) | -$3.80M(0.0%) |
Mar 1994 | - | -$900.00K(-18.2%) | -$3.80M(+2.7%) |
Dec 1993 | -$3.90M(+39.3%) | -$1.10M(+22.2%) | -$3.70M(+12.1%) |
Sep 1993 | - | -$900.00K(0.0%) | -$3.30M(+6.5%) |
Jun 1993 | - | -$900.00K(+12.5%) | -$3.10M(+1450.0%) |
Mar 1993 | - | -$800.00K(+14.3%) | -$200.00K(<-9900.0%) |
Dec 1992 | -$2.80M(+55.6%) | -$700.00K(0.0%) | $0.00(-100.0%) |
Sep 1992 | - | -$700.00K(-135.0%) | $200.00K(-60.0%) |
Jun 1992 | - | $2.00M(-433.3%) | $500.00K(-125.0%) |
Mar 1992 | - | -$600.00K(+20.0%) | -$2.00M(+42.9%) |
Dec 1991 | -$1.80M | -$500.00K(+25.0%) | -$1.40M(+55.6%) |
Sep 1991 | - | -$400.00K(-20.0%) | -$900.00K(+80.0%) |
Jun 1991 | - | -$500.00K | -$500.00K |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual cost of goods sold?
- What is the all time high annual cost of goods sold for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual cost of goods sold year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold year-on-year change?
- What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual cost of goods sold?
The current annual cost of goods sold of VRTX is $1.53B
What is the all time high annual cost of goods sold for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual cost of goods sold is $1.53B
What is Vertex Pharmaceuticals Incorporated annual cost of goods sold year-on-year change?
Over the past year, VRTX annual cost of goods sold has changed by +$268.30M (+21.26%)
What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold?
The current quarterly cost of goods sold of VRTX is $363.00M
What is the all time high quarterly cost of goods sold for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly cost of goods sold is $423.40M
What is Vertex Pharmaceuticals Incorporated quarterly cost of goods sold year-on-year change?
Over the past year, VRTX quarterly cost of goods sold has changed by +$20.40M (+5.95%)
What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold?
The current TTM cost of goods sold of VRTX is $1.55B
What is the all time high TTM cost of goods sold for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high TTM cost of goods sold is $1.55B
What is Vertex Pharmaceuticals Incorporated TTM cost of goods sold year-on-year change?
Over the past year, VRTX TTM cost of goods sold has changed by +$213.00M (+15.92%)